121 related articles for article (PubMed ID: 32791502)
1. Genetic Variants in One-Carbon Metabolism Pathway Predict Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer.
Do SK; Choi SH; Lee SY; Choi JE; Kang HG; Hong MJ; Kim JH; Baek SA; Lee JH; Lee WK; Do YW; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
Oncology; 2020; 98(12):897-904. PubMed ID: 32791502
[TBL] [Abstract][Full Text] [Related]
2. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
3. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
[TBL] [Abstract][Full Text] [Related]
4. Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Do SK; Choi SH; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
Gene; 2019 Jun; 703():58-64. PubMed ID: 30954677
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
Seok Y; Kang HG; Lee SY; Jeong JY; Choi JE; Jung DK; Jin CC; Hong MJ; Do SK; Lee WK; Park JY; Shin KM; Yoo SS; Lee J; Cho S; Cha SI; Kim CH; Jheon S; Lee EB; Park JY
Ann Surg Oncol; 2017 Oct; 24(11):3386-3395. PubMed ID: 28766235
[TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
[TBL] [Abstract][Full Text] [Related]
8. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Do SK; Jeong JY; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Seok Y; Lee EB; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Neugent ML; Goodwin J; Kim JW; Park JY
Ann Surg Oncol; 2018 Oct; 25(11):3396-3403. PubMed ID: 30062472
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.
Kim M; Kang HG; Lee SY; Lee HC; Lee EB; Choi YY; Lee WK; Cho S; Jin G; Jheon HS; Son JW; Lee MH; Jung DK; Cha SI; Kim CH; Kang YM; Kam S; Jung TH; Jheon S; Park JY
Cancer Sci; 2010 Nov; 101(11):2436-42. PubMed ID: 20731661
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
[TBL] [Abstract][Full Text] [Related]
11. A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection.
Lee SY; Choi JE; Jeon HS; Choi YY; Lee WK; Lee EB; Lee HC; Kang HG; Yoo SS; Lee J; Cha SI; Kim CH; Lee MH; Kim YT; Jheon S; Park JY
PLoS One; 2015; 10(10):e0140216. PubMed ID: 26462029
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer.
Lee SY; Jin CC; Choi JE; Hong MJ; Jung DK; Do SK; Baek SA; Kang HJ; Kang HG; Choi SH; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Lee YM; Lee IK; Jheon S; Park JY
Sci Rep; 2016 Oct; 6():35603. PubMed ID: 27767175
[TBL] [Abstract][Full Text] [Related]
13. Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancer.
Shin KM; Hong MJ; Lee SY; Jin CC; Baek SA; Lee JH; Choi JE; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Kim YC; Oh IJ; Na KJ; Cho S; Jheon S; Park JY
Gene; 2018 Mar; 646():56-63. PubMed ID: 29289609
[TBL] [Abstract][Full Text] [Related]
14. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
15. RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer.
Choi YY; Lee SY; Lee WK; Jeon HS; Lee EB; Lee HC; Choi JE; Kang HG; Lee EJ; Bae EY; Yoo SS; Lee J; Cha SI; Kim CH; Kim IS; Lee MH; Kim YT; Jheon S; Park JY
Oncotarget; 2015 Feb; 6(6):4451-66. PubMed ID: 25686824
[TBL] [Abstract][Full Text] [Related]
16. TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery.
Lee YH; Do SK; Lee SY; Kang HG; Choi JE; Hong MJ; Lee JH; Lee EB; Jeong JY; Shin KM; Lee WK; Seok Y; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Jheon S; Park JY
Thorac Cancer; 2019 Feb; 10(2):335-340. PubMed ID: 30585697
[TBL] [Abstract][Full Text] [Related]
17. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.
Zhao T; Gu D; Xu Z; Huo X; Shen L; Wang C; Tang Y; Wu P; He J; Gong W; He ML; Chen J
Oncotarget; 2015 Apr; 6(11):9564-76. PubMed ID: 25840420
[TBL] [Abstract][Full Text] [Related]
19. Lipid Metabolism Pathway Genes and Lung Cancer: ACADSB rs12220683G>C Is Associated with Better Survival Outcome in Patients with Non-Small Cell Lung Cancer.
Yoo SS; Do SK; Choi JE; Kang HG; Hong MJ; Lee JH; Lee WK; Do YW; Lee EB; Park JE; Choi SH; Seo H; Lee YH; Lee J; Lee SY; Cha SI; Kim CH; Park JY
Oncology; 2024; 102(1):67-75. PubMed ID: 37527640
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]